SofWave Medical Ltd. (TLV:SOFW)
Israel
· Delayed Price · Currency is ILS · Price in ILA 2,015.00
-27.00 (-1.32%)
May 15, 2025, 4:54 PM IDT
SofWave Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 63.14 | 59.65 | 50.32 | 35.63 | 21.84 | 4.29 | Upgrade
|
| Revenue Growth (YoY) | 18.92% | 18.55% | 41.22% | 63.15% | 408.95% | 1443.53% | Upgrade
|
| Cost of Revenue | 15.14 | 14.46 | 13.01 | 9.3 | 5.63 | 1.67 | Upgrade
|
| Gross Profit | 48 | 45.2 | 37.3 | 26.33 | 16.21 | 2.62 | Upgrade
|
| Selling, General & Admin | 40.51 | 38.15 | 34.04 | 31.23 | 17 | 4.59 | Upgrade
|
| Research & Development | 11.07 | 10.63 | 11.25 | 12.44 | 8.21 | 4.58 | Upgrade
|
| Other Operating Expenses | - | - | - | -0 | - | - | Upgrade
|
| Operating Expenses | 51.58 | 48.78 | 45.29 | 43.67 | 25.21 | 9.17 | Upgrade
|
| Operating Income | -3.58 | -3.58 | -7.99 | -17.34 | -9 | -6.55 | Upgrade
|
| Interest Expense | -0.24 | -0.06 | -0.06 | -0.19 | -0.11 | -0.04 | Upgrade
|
| Interest & Investment Income | 0.67 | 0.7 | 0.78 | 0.33 | 0.03 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.02 | -1.07 | 2.26 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.13 | -1.13 | -1 | -0.94 | -0.46 | -0.3 | Upgrade
|
| EBT Excluding Unusual Items | -4.28 | -4.06 | -8.26 | -19.21 | -7.28 | -6.98 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.14 | -4.7 | Upgrade
|
| Pretax Income | -4.28 | -4.06 | -8.26 | -19.21 | -7.15 | -11.69 | Upgrade
|
| Income Tax Expense | 0.4 | 0.49 | 0.02 | 0.32 | -0.32 | - | Upgrade
|
| Net Income | -4.68 | -4.55 | -8.28 | -19.53 | -6.83 | -11.69 | Upgrade
|
| Net Income to Common | -4.68 | -4.55 | -8.28 | -19.53 | -6.83 | -11.69 | Upgrade
|
| Shares Outstanding (Basic) | 35 | 34 | 34 | 34 | 23 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 34 | 34 | 34 | 23 | 43 | Upgrade
|
| Shares Change (YoY) | 1.09% | 0.53% | 0.26% | 44.98% | -45.50% | 5.31% | Upgrade
|
| EPS (Basic) | -0.14 | -0.13 | -0.24 | -0.57 | -0.29 | -0.27 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.13 | -0.24 | -0.57 | -0.29 | -0.27 | Upgrade
|
| Free Cash Flow | -2.67 | -2.67 | -6.71 | -11.14 | -5.22 | -5.08 | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.08 | -0.20 | -0.33 | -0.22 | -0.12 | Upgrade
|
| Gross Margin | 76.03% | 75.77% | 74.14% | 73.90% | 74.21% | 61.06% | Upgrade
|
| Operating Margin | -5.67% | -6.00% | -15.88% | -48.66% | -41.22% | -152.67% | Upgrade
|
| Profit Margin | -7.40% | -7.62% | -16.45% | -54.81% | -31.26% | -272.36% | Upgrade
|
| Free Cash Flow Margin | -4.23% | -4.48% | -13.34% | -31.27% | -23.90% | -118.39% | Upgrade
|
| EBITDA | -2.24 | -2.22 | -7.13 | -16.22 | -8.87 | -6.52 | Upgrade
|
| EBITDA Margin | -3.54% | -3.73% | -14.17% | -45.52% | -40.62% | -151.88% | Upgrade
|
| D&A For EBITDA | 1.34 | 1.36 | 0.86 | 1.12 | 0.13 | 0.03 | Upgrade
|
| EBIT | -3.58 | -3.58 | -7.99 | -17.34 | -9 | -6.55 | Upgrade
|
| EBIT Margin | -5.67% | -6.00% | -15.88% | -48.66% | -41.22% | -152.67% | Upgrade
|
| Advertising Expenses | - | 8.23 | 4.68 | 3.85 | 1.45 | 0.44 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.